{"url_path":"/sec/sgmo/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-03-30","source_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","accession_number":"0001628280-26-022029","cik":"0001001233","ticker":"SGMO","issuer_name":"SANGAMO THERAPEUTICS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","primary_entity_key":"0001001233","primary_entity_name":"SANGAMO THERAPEUTICS, INC"},"word_count":113,"has_tables":true,"body_markdown":"ITEM 5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES\n\nMarket Information\n\nOur common stock trades on the Nasdaq Capital Market under the symbol “SGMO.”\n\nHolders\n\nAs of March 25, 2026, there were 49 holders of record of our common stock. This number does not include “street name,” or beneficial holders, whose shares are held of record by banks, brokers, financial institutions and other nominees.\n\nDividends\n\nWe have not paid dividends on our common stock, and currently do not plan to pay any cash dividends in the foreseeable future.\n\nUnregistered Sales of Equity Securities\n\nNone.\n\nPurchases of Equity Securities by the Issuer and Affiliated Purchasers\n\nNone."}